chr11-122796191-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_032873.5(UBASH3B):c.1149G>A(p.Lys383=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,614,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000028 ( 0 hom. )
Consequence
UBASH3B
NM_032873.5 synonymous
NM_032873.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
UBASH3B (HGNC:29884): (ubiquitin associated and SH3 domain containing B) This gene encodes a protein that contains a ubiquitin associated domain at the N-terminus, an SH3 domain, and a C-terminal domain with similarities to the catalytic motif of phosphoglycerate mutase. The encoded protein was found to inhibit endocytosis of epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 11-122796191-G-A is Benign according to our data. Variant chr11-122796191-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 747650.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.94 with no splicing effect.
BS2
High AC in GnomAd4 at 62 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UBASH3B | NM_032873.5 | c.1149G>A | p.Lys383= | synonymous_variant | 8/14 | ENST00000284273.6 | |
UBASH3B | NM_001363365.2 | c.1044G>A | p.Lys348= | synonymous_variant | 8/14 | ||
UBASH3B | XM_005271712.4 | c.1233G>A | p.Lys411= | synonymous_variant | 8/14 | ||
UBASH3B | XM_011543041.3 | c.1092G>A | p.Lys364= | synonymous_variant | 8/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UBASH3B | ENST00000284273.6 | c.1149G>A | p.Lys383= | synonymous_variant | 8/14 | 1 | NM_032873.5 | P1 | |
ENST00000649590.1 | n.74-30142C>T | intron_variant, non_coding_transcript_variant | |||||||
UBASH3B | ENST00000530578.1 | n.93G>A | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152216Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
62
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251384Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135858
GnomAD3 exomes
AF:
AC:
25
AN:
251384
Hom.:
AF XY:
AC XY:
9
AN XY:
135858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461842Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 727220
GnomAD4 exome
AF:
AC:
41
AN:
1461842
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74496
GnomAD4 genome
AF:
AC:
62
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
34
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 24, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at